Michael Pishvaian, MD, PhD

No bio available.

Financial relationships

  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Seattle Genetics
    Topic:
    Funding for my Institution
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Tesaro
    Topic:
    Funding for my Institution
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Arcus Bio
    Topic:
    Funding for my Institution
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Ideaya
    Topic:
    Funding for my Institution
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Repare Tx
    Topic:
    Funding for my Institution
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Novartis
    Topic:
    Funding for my Institution
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Pfizer
    Topic:
    Funding for my Institution
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Topic:
    Funding for my Institution
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Tizonia
    Topic:
    Funding for my Institution
    Date added:
    08/16/2023
    Date updated:
    08/16/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Biomed Valley Discoveries
    Topic:
    Funding for my Institution
    Date added:
    08/16/2023
    Date updated:
    08/16/2023

Pages

Return to 2023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond